6 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... ivermectin… #COVID19 ... Pandemic #Outbreak #InfectiousDiseases ... #Antiviral #Management ... #Ivermectin #Antiparasite
Trends in invasive mechanical ventilation, hydroxychloroquine, remdesivir, and corticosteroids in the US from April to July
#clinical #COVID19 ... #management #COVID ... #coronavirus #infectiousdiseases
This is an oversimplified, hypothetical model to think about time from symptom onset and stages of
of disease in COVID ... #COVID19 #COVID ... #infectiousdisease ... #clinical #management
COVID-19 Hypoxia Management

Indication for endotracheal intubation?
Tolerating supplemental oxygen?
Consider HFNC
Not tolerating HFNC or HFNC is not available?
Consider
COVID-19 Hypoxia ... Management Indication ... Society of Critical ... #management #schema ... criticalcare #hypoxia #failure
General schema for respiratory support in patients with COVID-19
Low flow nasal cannula
 • Typically set at
patients with COVID ... volumes of ~6 cc ... Internet Book of Critical ... #management #schema ... criticalcare #hypoxia #failure
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
like illnesses, COVID ... 19 - Zika virus ... meningococcal, H1N1) Clinical ... Guillain-Barre Clinical ... Syndrome #diagnosis #management